601089
Beijing Foyou Pharma Gets Nod to Market Ferrous Succinate Tablets Beijing Foyou Pharma (SHA:601089) received a drug registration certificate from Chinese drug regulator National Medical Products Administration for its ferrous succinate tablets, according to a Wednesday filing on the Shanghai Stock Exchange.The pharmaceutical company is now allowed to market the drug used for the prevention and treatment of iron deficiency anemia, the filing said.Price (RMB): ¥14.94, Change: ¥+0.0100, Percent Change: +0.07%
时间：2024-09-11 12:45:20 市场： 美股 综合 A股